Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA Nogueira, CP Oliveira, VAF Alves, JT Stefano… - Clinical Nutrition, 2016 - Elsevier
Background & aims: Few clinical trials have addressed the potential benefits of omega-3
polyunsaturated fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated …

[引用][C] Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial

MA Nogueira, HV Barbeiro, FJ Carrilho… - Clinical …, 2016 - repositorio.usp.br
ReP USP - Detalhe do registro: Omega-3 polyunsaturated fatty acids in treating non-alcoholic
steatohepatitis: a randomized, double-blind, placebo-controlled trial Home About USP Schools …

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA Nogueira, CP Oliveira, VAF Alves, JT Stefano… - 2016 - pubmed.ncbi.nlm.nih.gov
Background & aims: Few clinical trials have addressed the potential benefits of omega-3
polyunsaturated fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated …

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA NOGUEIRA, CP OLIVEIRA, VAF ALVES… - Clinical …, 2016 - observatorio.fm.usp.br
Background: & aims: Few clinical trials have addressed the potential benefits of omega-3
polyunsaturated fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated …

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA Nogueira, CP Oliveira, VAF Alves… - Clinical …, 2016 - clinicalnutritionjournal.com
Background & aims: Few clinical trials have addressed the potential benefits of omega-3
polyunsaturated fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated …

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA Nogueira, CP Oliveira, VAF Alves, JT Stefano… - Clinical Nutrition, 2016 - infona.pl
& aims: Few clinical trials have addressed the potential benefits of omega-3 polyunsaturated
fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated the effects of …

[PDF][PDF] Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA Nogueira, CP Oliveira, VAF Alves, JT Stefano… - Clinical …, 2016 - researchgate.net
Background: & aims: Few clinical trials have addressed the potential benefits of omega-3
polyunsaturated fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated …

[PDF][PDF] Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA Nogueira, CP Oliveira, VAF Alves, JT Stefano… - Clinical …, 2015 - academia.edu
Background: & aims: Few clinical trials have addressed the potential benefits of omega-3
polyunsaturated fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated …

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial.

MA Nogueira, CP Oliveira, VAF Alves, JT Stefano… - 2016 - cabidigitallibrary.org
Background & aims: Few clinical trials have addressed the potential benefits of omega-3
polyunsaturated fatty acids (PUFAs) on non-alcoholic steatohepatitis (NASH). We evaluated …

[引用][C] Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

MA Nogueira, CP Oliveira, VAF Alves, JT Stefano… - 2016